Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
EXAS Exact Sciences Corporation daily Stock Chart
EXAS [NASD]
Exact Sciences Corporation
Healthcare | Medical Laboratories & Research | USA
statements
Index- P/E- EPS (ttm)-1.76 Insider Own0.30% Shs Outstand129.18M Perf Week7.59%
Market Cap12.58B Forward P/E- EPS next Y-0.81 Insider Trans-16.31% Shs Float127.75M Perf Month-7.63%
Income-220.80M PEG- EPS next Q-0.40 Inst Own89.20% Short Float9.99% Perf Quarter-15.22%
Sales623.20M P/S20.19 EPS this Y30.70% Inst Trans0.20% Short Ratio6.92 Perf Half Y5.62%
Book/sh5.93 P/B16.42 EPS next Y53.40% ROA-13.40% Target Price132.82 Perf Year44.41%
Cash/sh9.59 P/C10.15 EPS next 5Y20.00% ROE-30.00% 52W Range53.06 - 123.99 Perf YTD54.34%
Dividend- P/FCF- EPS past 5Y-15.80% ROI-11.60% 52W High-21.45% Beta1.39
Dividend %- Quick Ratio2.70 Sales past 5Y155.90% Gross Margin73.80% 52W Low83.55% ATR3.72
Employees1977 Current Ratio2.80 Sales Q/Q94.30% Oper. Margin-32.50% RSI (14)47.32 Volatility3.59% 4.12%
OptionableYes Debt/Eq1.05 EPS Q/Q0.20% Profit Margin-35.40% Rel Volume0.59 Prev Close97.58
ShortableYes LT Debt/Eq0.65 EarningsOct 29 AMC Payout- Avg Volume1.84M Price97.39
Recom1.30 SMA202.57% SMA50-9.48% SMA200-2.34% Volume1,089,843 Change-0.19%
Oct-17-19Reiterated BofA/Merrill Buy $130 → $135
Oct-01-19Resumed Craig Hallum Buy $127
Sep-26-19Initiated Oppenheimer Outperform $130
Feb-26-19Upgrade Goldman Neutral → Buy $85 → $120
Oct-09-18Initiated UBS Buy
Sep-05-18Resumed The Benchmark Company Hold
Aug-13-18Reiterated Canaccord Genuity Buy $62 → $65
Apr-03-18Upgrade BTIG Research Neutral → Buy
Jan-29-18Initiated Goldman Neutral $51
Jan-08-18Reiterated The Benchmark Company Buy $60 → $65
Nov-13-17Downgrade Robert W. Baird Outperform → Neutral $56
Nov-01-17Downgrade BTIG Research Buy → Neutral
Oct-31-17Reiterated The Benchmark Company Buy $50 → $60
Oct-03-17Reiterated Canaccord Genuity Buy $45 → $60
Sep-21-17Reiterated Leerink Partners Outperform $45 → $50
Jul-26-17Reiterated Lake Street Hold $30 → $41
Jul-26-17Reiterated Canaccord Genuity Buy $42 → $45
May-31-17Reiterated The Benchmark Company Buy $34 → $50
May-31-17Reiterated Canaccord Genuity Buy $38 → $40
Apr-17-17Initiated Leerink Partners Outperform $30
Oct-17-19 10:57AM  Moore Kuehn, PLLC Encourages Genomic Health, Inc. and Carbonite, Inc. Investors to Contact Firm PR Newswire
Oct-16-19 07:10PM  Spiros Segalas' Top 5 Buys in the 3rd Quarter GuruFocus.com
Oct-14-19 06:00AM  Exact Sciences And Mayo Clinic Initiate 150,000 Patient, 7-Year Study To Evaluate Real-World Impact Of Cologuard® PR Newswire
Oct-11-19 12:53PM  Emergent's Chikungunya Vaccine Candidate Gets EMA's PRIME Tag Zacks
12:40PM  Seattle Genetics Begins Phase III Study on Tucatinib Combo Zacks
11:08AM  Do Hedge Funds Love EXACT Sciences Corporation (EXAS)? Insider Monkey
07:24AM  What Did Exact Sciences Corporation's (NASDAQ:EXAS) CEO Take Home Last Year? Simply Wall St.
Oct-10-19 11:17AM  bluebird Inks Genome Editing Research Deal With Novo Nordisk Zacks
11:15AM  Seattle Genetics Up More Than 20% in 3 Months: Here's Why Zacks
Oct-08-19 09:30AM  Has Exact Sciences (EXAS) Outpaced Other Medical Stocks This Year? Zacks
06:00AM  Exact Sciences schedules third-quarter 2019 earnings call PR Newswire
Oct-04-19 10:09PM  Inside Genomic Health's $2.8B deal: A false start, rejections and a mysterious last-minute party American City Business Journals
Oct-03-19 12:46PM  Exact Sciences continues down strong growth path American City Business Journals +5.90%
Sep-26-19 10:51AM  3 Strong Buy Mid-Cap Stocks with High Upside TipRanks
Sep-25-19 09:18AM  Exact Sciences Corporation Enters Oversold Territory Zacks
Sep-24-19 11:19AM  Exact Sciences: Finding the Exact Price to Buy the Stock TheStreet.com
11:18AM  Cramer Weighs In On PayPal, NextEra And More Benzinga
09:10AM  Exact Sciences Gets FDA Nod for Label Expansion of Cologuard Zacks
Sep-23-19 04:15PM  How A New Approval Could Help This Biotech Stock Add $3 Billion In Sales Investor's Business Daily
03:46PM  PreMarket Prep Recap: Fitbit, Exact Sciences Headlines; US Steel Downgrade 'A Bit Late To The Party' Benzinga
01:06PM  Exact Sciences gains $3B market opportunity as FDA approves Cologuard for 45 and older American City Business Journals
10:11AM  Exact Sciences Stock Takes Off as FDA Approves Colon-Cancer Test for Younger People Barrons.com
06:23AM  Exact Sciences Lifted to Buy at Benchmark on Wider Cologuard-Use Approval TheStreet.com
05:45AM  Cologuard® Gains FDA Approval For Use In Younger Americans, Ages 45 To 49 PR Newswire
Sep-20-19 10:49AM  Zacks Value Trader Highlights: Exact Sciences, Edwards Lifesciences, Bristol Myers-Squibb, Occidental Petroleum and Exxon Mobil Zacks
Sep-19-19 11:05AM  Stock Investors: Do You Need a Late Cycle Plan? Zacks
08:35AM  Exact Sciences Named One of the 2019 Best Workplaces for Women by Great Place to Work® and FORTUNE PR Newswire
Sep-10-19 06:00AM  Cologuard® Helps More People Get Screened In A Cost-Effective Way PR Newswire
Sep-05-19 10:41AM  Is Exact Sciences (NASDAQ:EXAS) Weighed On By Its Debt Load? Simply Wall St.
Aug-30-19 09:15AM  Exact Sciences to participate in September investor conference PR Newswire
Aug-28-19 10:38AM  The Zacks Analyst Blog Highlights: Bristol-Myers Squibb Company, Celgene, Exact Sciences, Pfizer and Guardant Health Zacks
Aug-27-19 09:24AM  3 Cancer Treatment Stocks to Enrich Your Portfolio Zacks
Aug-20-19 05:17PM  Third in wave of Bay Area biotech IPOs eyes $100M windfall after 26 years in business American City Business Journals
Aug-16-19 01:10PM  A Breach of Trust? Here's Why the FDA's Taking Aim at Novartis' AveXis Motley Fool
Aug-08-19 01:03PM  10 Stocks That Can Profit as Global Turmoil Escalates Investopedia
Aug-07-19 10:05AM  Genomic Health's Second Quarter Was So Great It Got the Company Acquired Motley Fool
Aug-05-19 04:20PM  Here's Why Genetic Testing Stocks Rose as Much as 25.4% in July Motley Fool -5.73%
Aug-02-19 05:18PM  GENOMIC HEALTH INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Genomic Health, Inc. - GHDX PR Newswire
06:00AM  Exact Sciences to participate in August investor conference PR Newswire
Aug-01-19 07:20PM  Acquisition Boosts Exact Sciences' Role in Cancer Diagnostics GuruFocus.com
Jul-31-19 09:15PM  Exact Sciences Corp (EXAS) CFO Jeffrey Thomas Elliott Sold $1 million of Shares GuruFocus.com
09:42AM  Pioneering cancer test maker's execs could grab millions in $3 billion buyout American City Business Journals
09:25AM  7 Strong Buy Stocks the Street Loves InvestorPlace
08:50AM  Short Seller Left Goes Long on Invitae With $100 Target TheStreet.com
08:26AM  A Look At The Fair Value Of Exact Sciences Corporation (NASDAQ:EXAS) Simply Wall St.
Jul-30-19 05:24PM  Exact Sciences Corp (EXAS) Q2 2019 Earnings Call Transcript Motley Fool
04:55PM  Why Exact Science Made the $2.8 Billion Deal for Genomic Bloomberg
07:27AM  Here's Why Exact Sciences Stock Snapped Right Back Into Place Motley Fool
06:17AM  Exact Sciences Is Poised to Test New Highs on the Charts TheStreet.com
Jul-29-19 08:00PM  SHAREHOLDER ALERT: WeissLaw LLP Investigates Genomic Health, Inc. PR Newswire
04:11PM  Merger Fever Runs Hot In Pharma: Viagra, Epipen Sellers Announce Matchup Investor's Business Daily
03:01PM  Exact Sciences, Genomic deal will yield greater cancer diagnostic R&D in $20B market American City Business Journals
02:42PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Genomic Health, Inc. to Exact Sciences Corp. is Fair to Shareholders GlobeNewswire
02:37PM  Exact Sciences Stock Breaks Down After Merger Agreement Investopedia
11:43AM  Why Exact Sciences Is Sinking and Genomic Health Is Rising Motley Fool
10:48AM  Madison's Exact Sciences to buy cancer diagnostic company in $2.8B deal American City Business Journals
10:05AM  Exact Sciences to Buy Genomic Health for About $2.8 Billion Bloomberg
09:29AM  Stocks - Mylan, Uber Rise Premarket; Pfizer, Dominos Fall Investing.com
08:25AM  Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates Zacks
08:07AM  Exact Sciences Will Acquire Genomic Health In $2.8B Deal Benzinga
07:32AM  UPDATE 2-Diagnostic company Exact Sciences to buy Genomic Health in $2.8 bln deal Reuters
07:24AM  Diagnostic company Exact Sciences to buy Genomic Health in $2.8 billion deal Reuters
07:23AM  Exact Sciences to combine with Genomic Health in cash and stock deal valued at $2.8 billion MarketWatch
07:08AM  Exact Sciences to buy Genomic Health for $2.8 billion Reuters
07:01AM  Second-quarter revenue increased 94 percent to $200 million and Cologuard test volume increased 93 percent to 415,000 PR Newswire
07:00AM  Exact Sciences and Genomic Health to Combine, Creating Leading Global Cancer Diagnostics Company PR Newswire
05:53AM  Exact Sciences Reaches Deal to Acquire Genomic Health for $2.8 Billion TheStreet.com
02:37AM  [video]Exact Sciences in Talks to Buy Genomic Health - Report TheStreet.com
Jul-27-19 06:52PM  Exact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg Reuters
06:47PM  Exact Sciences in advanced talks to buy Genomic Health for $2.8 bln- Bloomberg Reuters
Jul-23-19 10:32AM  Earnings Preview: Exact Sciences (EXAS) Q2 Earnings Expected to Decline Zacks
Jul-17-19 06:00AM  Exact Sciences Designated a Great Place to Work-Certified Company in 2019 PR Newswire
Jul-10-19 11:49AM  10 Stocks to Sell for an Economic Slowdown InvestorPlace
Jul-09-19 09:41AM  Heres why investors should keep the faith in U.S. stocks: BlackRock MarketWatch
06:00AM  Exact Sciences to host annual meeting, second-quarter 2019 results webcasts and calls PR Newswire
Jul-08-19 10:07AM  Why Exact Sciences Corporation Stock Gained Nearly 14% in June Motley Fool
Jun-26-19 04:05PM  Exact Sciences Advances Fight Against Colorectal Cancer With Opening Of New Laboratory PR Newswire
Jun-25-19 03:06PM  What Kind Of Shareholders Own Exact Sciences Corporation (NASDAQ:EXAS)? Simply Wall St.
Jun-17-19 05:51PM  Hedge Funds Have Never Been More Bullish On EXACT Sciences Corporation (EXAS) Insider Monkey
Jun-04-19 07:35AM  Jim Cramer Gives His Opinion On Wendy's, Exelon And More Benzinga
May-31-19 06:00AM  Exact Sciences to participate in June investor conferences PR Newswire
May-28-19 08:46AM  The Zacks Analyst Blog Highlights: Guardant, Illumina, Exact Sciences and Pfizer Zacks
May-24-19 09:25AM  3 Stocks to Win Big in the Fight Against Cancer Zacks
May-23-19 03:03PM  Exact Sciences Corporation (NASDAQ:EXAS): When Will It Breakeven? Simply Wall St.
May-20-19 08:56AM  Exact Sciences Advances Pipeline Capabilities with Mayo Clinic PR Newswire
May-17-19 05:30AM  Exact Sciences Presents New Data Reinforcing Performance of Cologuard® PR Newswire
May-16-19 04:59PM  Exact Sciences returning $61K in WEDC tax credits because jobs were created outside Wisconsin: AP American City Business Journals
May-15-19 08:15AM  3 Top Healthcare Stocks to Buy in May Motley Fool
May-11-19 12:01PM  Guardant Health Takes Aim at Exact Sciences Motley Fool
May-09-19 09:00AM  Why Exact Sciences Shrugged Off the Moody Market in April Motley Fool
May-02-19 05:04PM  The stock markets reaction to this one word from the Feds Powell shows investors should be careful MarketWatch
05:46AM  Edited Transcript of EXAS earnings conference call or presentation 30-Apr-19 9:00pm GMT Thomson Reuters StreetEvents
May-01-19 06:22AM  Exact Sciences Corp (EXAS) Q1 2019 Earnings Call Transcript Motley Fool
06:00AM  Exact Sciences to participate in May investor conferences PR Newswire
Apr-30-19 09:30PM  What You'll Want to Know About Exact Sciences' Q1 Earnings Motley Fool
06:00PM  Exact Sciences: 1Q Earnings Snapshot Associated Press
05:24PM  Exact Sciences reports 79% jump in Cologuard test volume, first-quarter revenue American City Business Journals
04:05PM  First-quarter revenue and Cologuard test volume increased 79 percent to $162 million and 334,000, respectively PR Newswire
03:00PM  EXACT Sciences Corp. to Host Earnings Call ACCESSWIRE
11:45AM  The 5 Hottest Earnings Charts This Week Zacks
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Johnson Scott C.SVP - Research and DevelopmentSep 12Sale108.633,527383,13812,311Sep 13 04:52 PM
Johnson Scott C.SVP - Research and DevelopmentSep 11Option Exercise0.007,500015,838Sep 13 04:52 PM
LEVANGIE DANIEL JDirectorJul 31Option Exercise5.3142,607226,42155,065Aug 02 04:24 PM
WYZGA MICHAEL SDirectorJul 31Option Exercise26.982,50067,45013,913Aug 02 04:25 PM
LEVANGIE DANIEL JDirectorJul 31Sale117.6442,6075,012,39812,458Aug 02 04:24 PM
Zanotti Katherine SDirectorJul 31Sale117.931,744205,67077,513Aug 02 04:28 PM
WYZGA MICHAEL SDirectorJul 31Sale117.935,000589,6508,913Aug 02 04:25 PM
Doyle James EdwardDirectorJul 31Sale117.932,808331,14734,440Aug 02 04:22 PM
Carey Thomas D.DirectorJul 31Sale117.6510,0001,176,48734,181Aug 02 04:20 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 30Sale105.609,8451,039,63249,917Jul 31 05:57 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 29Option Exercise0.0018,750059,762Jul 31 05:57 PM
Stenhouse MarkPresident, CologuardApr 03Sale92.5411,1921,035,69614,308Apr 04 04:24 PM
Stenhouse MarkPresident, CologuardApr 02Option Exercise0.0025,000025,500Apr 04 04:24 PM
COWARD D SCOTTChief Administrative OfficerMar 11Sale87.212,774241,926103,096Mar 12 05:19 PM
Conroy Kevin TPresident and CEOMar 11Sale87.2111,227979,129938,526Mar 12 05:16 PM
COWARD D SCOTTChief Administrative OfficerMar 09Option Exercise0.006,0250105,870Mar 12 05:19 PM
Conroy Kevin TPresident and CEOMar 09Option Exercise0.0024,4000949,753Mar 12 05:16 PM
Zanotti Katherine SDirectorFeb 28Sale92.8125,0002,320,23177,102Mar 01 05:36 PM
WYZGA MICHAEL SDirectorFeb 28Sale96.0050048,0008,612Mar 01 05:34 PM
Johnson Scott C.SVP - Research and DevelopmentFeb 28Sale93.201,166108,6767,652Mar 01 05:32 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 28Sale93.202,447228,07040,644Mar 01 05:29 PM
Doyle James EdwardDirectorFeb 28Sale96.002,000192,00035,093Mar 01 05:25 PM
COWARD D SCOTTChief Administrative OfficerFeb 28Sale93.202,447228,07099,845Mar 01 05:24 PM
Conroy Kevin TPresident and CEOFeb 28Sale93.2010,014933,345925,353Mar 01 05:21 PM
Carey Thomas D.DirectorFeb 28Sale96.007,500720,00041,483Mar 01 05:19 PM
Conroy Kevin TPresident and CEOFeb 27Option Exercise0.0020,5750935,367Feb 28 08:10 PM
Johnson Scott C.SVP - Research and DevelopmentFeb 27Option Exercise0.003,52508,818Feb 28 08:20 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27Option Exercise0.005,025043,091Feb 28 08:18 PM
COWARD D SCOTTChief Administrative OfficerFeb 27Option Exercise0.005,0250102,292Feb 28 08:15 PM
Conroy Kevin TPresident and CEOFeb 27Sale95.079,169871,734914,792Feb 28 08:10 PM
COWARD D SCOTTChief Administrative OfficerFeb 27Sale95.079,803932,01097,267Feb 28 08:15 PM
COWARD D SCOTTChief Administrative OfficerFeb 26Option Exercise0.0021,4000107,070Feb 28 08:15 PM
Conroy Kevin TPresident and CEOFeb 26Option Exercise0.0020,0250923,961Feb 28 08:10 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 25Sale90.554,445402,49938,066Feb 26 05:34 PM
COWARD D SCOTTChief Administrative OfficerFeb 25Sale90.556,143556,25585,670Feb 26 05:32 PM
Conroy Kevin TPresident and CEOFeb 25Sale90.5516,4001,485,036903,936Feb 26 05:29 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 23Option Exercise0.009,300042,511Feb 26 05:34 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Option Exercise0.0012,850091,813Feb 26 05:32 PM
Conroy Kevin TPresident and CEOFeb 23Option Exercise0.0034,3250920,336Feb 26 05:29 PM
Conroy Kevin TPresident and CEOJan 25Sale81.27304,39724,737,400886,011Jan 25 06:46 PM
Conroy Kevin TPresident and CEOJan 24Option Exercise0.00304,39701,190,408Jan 25 06:46 PM
COWARD D SCOTTChief Administrative OfficerJan 24Sale78.21169,10913,226,22678,963Jan 25 06:47 PM
Elliott Jeffrey ThomasChief Financial OfficerJan 24Sale78.9090,9097,172,54833,211Jan 25 06:48 PM
COWARD D SCOTTChief Administrative OfficerJan 23Option Exercise0.00169,1090248,072Jan 25 06:47 PM
Elliott Jeffrey ThomasChief Financial OfficerJan 23Option Exercise0.0090,9090124,120Jan 25 06:48 PM
COWARD D SCOTTChief Administrative OfficerJan 03Sale62.751,58199,21478,963Jan 04 04:56 PM
COWARD D SCOTTChief Administrative OfficerJan 02Option Exercise0.004,687080,544Jan 04 04:56 PM
Conroy Kevin TPresident and CEONov 12Option Exercise0.83163,514135,7171,049,525Nov 14 05:09 PM
Zanotti Katherine SDirectorNov 12Option Exercise3.437,66726,298109,769Nov 14 05:11 PM
Conroy Kevin TPresident and CEONov 12Sale69.00163,51411,282,466886,011Nov 14 05:09 PM
Zanotti Katherine SDirectorNov 12Sale69.007,667529,023102,102Nov 14 05:11 PM
LIDGARD GRAHAM PETERChief Science OfficerNov 07Sale75.0169852,35728,700Nov 07 05:33 PM
LIDGARD GRAHAM PETERChief Science OfficerNov 05Sale75.0137,6132,821,27629,398Nov 07 05:33 PM
LIDGARD GRAHAM PETERChief Science OfficerNov 01Sale70.3357,5174,045,34267,011Nov 02 05:40 PM
LIDGARD GRAHAM PETERChief Science OfficerOct 31Sale75.3522,1561,669,499124,528Nov 02 05:40 PM
open in yahoo | open in reuters | open in google